Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

OBJECTIVES: Predictive factors for efficacy of bevacizumab in advanced ovarian cancer have remained elusive. We investigated ascites both as a prognostic factor and as a predictor of efficacy for bevacizumab. METHODS: Using data from GOG 0218, patients receiving cytotoxic therapy plus concurrent and...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Gynecol Oncol
Huvudupphovsmän: Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4600605/
https://ncbi.nlm.nih.gov/pubmed/26216729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2015.07.103
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk